CASE STUDY

Predict™ In Silico Tox Service

Innovative Biotech Company Reduces Development Program Timelines for Neurogenerative Disease Research Program

Setting New Standards in Computational Toxicology

The client is an innovative clinical-stage drug platform company, who have a specific focus in the development of medication to treat neurogenerative diseases.

Learn how they successfully deployed Instem’s Predict™ In Silico Tox Service to significantly reduce their development program timelines.

Enter your details below to download the case study.

First Name *

Last Name *

Job Title *

Company *

Email *

Country *

Opt-in to receive periodic industry insights, event invitations, product updates, and other information from Instem.

Comments